Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infusion Rate of 5% Albumin in Septic Patients
NCT03153306Phase 4Unknown
- Sponsor
- Hainan People's Hospital
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in sepsis, septic shock, sponsored by Hainan People's Hospital. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT03153306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03153306.